RSM logo
Journal of Medical Screening

Home Current issue Browse archive Alerts About the journal Feedback
 
J Med Screen 2008;15:143-148
doi:10.1258/jms.2008.008004
© 2008 Medical Screening Society

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goulard, H.
Right arrow Articles by Bloch, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Articles

French colorectal cancer screening pilot programme: results of the first round

Hélène Goulard  , Colorectal Cancer Screening Programme Evaluation, InVS, Département des Maladies Chroniques et des Traumatismes, Institut de Veille Sanitaire, Saint-Maurice, France; Department of Chronic Diseases and Trauma, French National Institute for Public Health Surveillance, Saint-Maurice, France

Marjorie Boussac-Zarebska, Data Manager , Colorectal, Cancer Screening Programme Evaluation, InVS, Département des Maladies Chroniques et des Traumatismes, Institut de Veille Sanitaire, Saint-Maurice, France; Department of Chronic Diseases and Trauma, French National Institute for Public Health Surveillance, Saint-Maurice, France

Rosemary Ancelle-Park, Coordinator , Cancer Screening Programmes, InVS, Département des Maladies Chroniques et des Traumatismes, Institut de Veille Sanitaire, Saint-Maurice, France; Department of Chronic Diseases and Trauma, French National Institute for Public Health Surveillance, Saint-Maurice, France

Juliette Bloch, Director , Chronic Disease Department, InVS, Département des Maladies Chroniques et des Traumatismes, Institut de Veille Sanitaire, Saint-Maurice, France; Department of Chronic Diseases and Trauma, French National Institute for Public Health Surveillance, Saint-Maurice, France

Correspondence to: Hélène Goulard, Département des Maladies Chroniques et des Traumatismes, Institut de Veille Sanitaire, 12 Rue du Val d'Osne, 94 415 Saint-Maurice, France; h.goulard{at}invs.sante.fr


Objectives In France, a national pilot population-based screening programme on colorectal cancer was set up in 2002. In 2006, 23 French districts were included, targeting a population of more than five million people. This programme offers biennial screening using the fecal occult blood test (FOBT) to average risk subjects aged between 50 and 74 years. People receive a letter inviting them to consult their GPs, who in turn provide the FOBT. People with a positive test result are proposed a full colonoscopy. The results of the programme's first-round performance indicators are presented.

Methods The monitoring centre collected data from GPs and gastroenterologists on follow-up and colonoscopy results for people who were screened positive. Data were transferred to the French Institute for Public Health Surveillance (InVS) for the analysis.

Results The overall participation rate for the 19 districts having completed a first screening round reached 42%. The overall positive test rate was 2.7%. In the eight districts with comprehensive follow-up data for the first round, 86% of colonoscopies were completed after a positive test. A total of 1615 people were diagnosed with cancer, and 4612 people with adenoma. The cancer detection rate reached 2.3%, it was higher in men than in women (3.4% versus 1.4%), and increased with age. Forty-three percent of invasive detected cancers were stage I, 24% stage II, 23% had lymph node involvement and 10% presented with distant metastasis.

Conclusion These results suggest that indicators are consistent with international references. During 2007–2008, the programme coverage will be progressively extended, and all 99 French districts should be actively involved in its implementation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Med ScreenHome page
H. Goulard, M. Boussac-Zarebska, R. Ancelle-Park, and J. Bloch
Erratum
J Med Screen, December 1, 2008; 15(4): 214 - 214.
[Full Text] [PDF]



Acute CT - A Primer of Emergency Imaging